Cancer News and Research

Latest Cancer News and Research

British people unaware that cervical cancer is linked to human papillomavirus (HPV)

Most people in the UK do not know that cervical cancer is linked to a common sexually transmitted virus, according to a Cancer Research UK study published on (Monday).

7 Jun 2004

Gemcitabine may help breast cancer patients with advanced disease live longer

Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study presented today at the American Society of Clinical Oncology (ASCO) annual meeting.

6 Jun 2004

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.

6 Jun 2004

Velcade major improvement over standard therapy for relapsed multiple myeloma

Early results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

6 Jun 2004

200 new therapies are being developed for prostate cancer

The Prostate Cancer Foundation (PCF) has announced that more than 200 new therapies are being developed for prostate cancer, many by researchers supported by the PCF. Substantially more prostate cancer therapies are in later stages of clinical development (Phases II and III) than ever before.

5 Jun 2004

Crucial discovery may help better diagnose and treat children with Hirschsprung disease

Researchers at Fox Chase Cancer Center have made a crucial discovery that may help physicians better diagnose and treat children with Hirschsprung disease, a debilitating and sometimes life-threatening ailment that causes bowel obstruction and involves an array of genetic changes.

5 Jun 2004

High school student makes significant contribution to breast cancer research

A high school student from Albany, New York, has made a significant contribution toward understanding how mutations to a gene called BRCA-1 contributes to hereditary breast cancer.

5 Jun 2004

New way to identify cell growth

In a discovery that has relevance in a variety of fields, including human health, UC Riverside Assistant Professor of Biochemistry Frank Sauer and colleagues at UC Riverside, in Germany, and in Wisconsin, have found a new way to identify when a living cell begins to grow.

5 Jun 2004

Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in the US

Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.

5 Jun 2004

New method for identifying proteins found in trace quantities in the blood

Using conventional technologies, researchers supported by the National Cancer Institute (Science Applications International Corporation-Frederick, Inc. (SAIC)) have developed a new method for identifying proteins found in trace quantities in the blood.

5 Jun 2004

Smokers who quit before the age of 35 have a reasonable chance to regain their health

A new analysis of data on smoking and health finds that smokers who quit before the age of 35 have a reasonable chance to regain their health over time and to live as long and as well as people who have never smoked.

5 Jun 2004

60,000 set to run in race for the cure

Participants at the Susan G. Komen Breast Cancer Foundation National Race for the Cure® were among the first to view a new breast cancer ribbon today as they descended on the National Mall.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004